M. G. CRANE, M.D., F.A.C.P.; J. J. HARRIS, M.D., F.A.C.P.; WILLIAM WINSOR III, M.D.
Twenty-two patients developed hypertension on oral contraceptive pills. Mean blood pressure of the group before, during, and after the medication was stopped was 125/76, 183/110, and 130/82 mm Hg, respectively. The average plasma renin activity, the renin substrate, and the aldosterone excretion rate were moderately elevated in the patients who were studied while on the oral contraceptives. In 8 of 10 patients studied 3 to 6 weeks after the medication had been stopped, plasma renin activity failed to have a normal increase in response to sodium restriction and standing. In 3 of 11 patients values were in the hyporesponsive range when they were tested 2 to 7 months later. Five patients were studied who developed hypertension 3 months to 5 years after starting to take a conjugated estrogen. Four became normotensive from 1 to 7 months after they stopped taking the estrogen. The two patients studied had a hyporesponsive plasma renin activity on repeat study in association with an elevated plasma renin substrate while they were taking the estrogen.
Learn more about subscription options.
Register Now for a free account.
CRANE MG, HARRIS JJ, WINSOR W. Hypertension, Oral Contraceptive Agents, and Conjugated Estrogens. Ann Intern Med. 1971;74:13–21. doi: 10.7326/0003-4819-74-1-13
Download citation file:
Published: Ann Intern Med. 1971;74(1):13-21.
Cardiology, Coronary Risk Factors, Hypertension, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only